By Marcelo Corrales Compagnucci
Extended Reality (XR) technologies like Virtual Reality (VR), Augmented Reality (AR), and Mixed Reality (MR), are revolutionizing healthcare. These tools, powered by artificial intelligence (AI), are enhancing how medical professionals work across various specialties such as cardiology, pharmacy, and neuroscience, improving precision and efficiency in ways previously unimaginable. Tools like IBM

Stephanie Tabashneck, PsyD, JD, is a Senior Fellow in Law and Applied Neuroscience at the Petrie-Flom Center and Center for Law, Brain and Behavior (CLBB) at Massachusetts General Hospital/Harvard Medical School. A forensic psychologist and an attorney, she focuses her research, practice, and teaching on neural development in children and adolescents, substance use issues,

By James G. Hodge, Jr. and Jennifer L. Piatt
Surrounding the U.S. Supreme Court’s withdrawal of the longstanding constitutional right to abortion in Dobbs v. Jackson Women’s Health Organization on June 24, 2022, multiple state supreme courts have done their own “about face” on reproductive rights. Motivated perhaps by the infamous leaked decision in Dobbs,

By Elaine Marshall, Isabel Geisler, L. Virginia Martinez, Krystal Abbott, and Katherine Hazen
Social drivers of health (SDOH), sometimes known as the social determinants of health, are factors in the social environment that shape individual and population health, including poverty, racism, housing, education, and employment. When judges decide cases that impact these social factors, their

By Vincent Joralemon
MDMA (also known as the club drug “molly” or “ecstasy”) is a Schedule I controlled substance — the most restrictive drug class with the most severe criminal consequences linked to it. But, perhaps not for long.
A recent effort to get MDMA approved by the U.S. Food and Drug Administration (FDA) for